Subscribe To Our Free Newsletter |
Biocon jumps after receiving SAHPRA approval for Tacrolimus capsules
Biocon added 3.31% to Rs 270.45 after the company has received an approval from South African Health Products Regulatory Authority (SAHPRA) for their vertically integrated, complex drug product Tacrolimus capsule in South Africa.